Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$979K Sell
8,184
-832
-9% -$104K ﹤0.01% 1425
2026
Q1
$1.03M Buy
9,016
+868
+11% +$87K 0.01% 1284
2025
Q4
$710K Buy
8,148
+1,165
+17% +$95.8K ﹤0.01% 1421
2025
Q3
$527K Sell
6,983
-1,589
-19% -$122K ﹤0.01% 1413
2025
Q2
$685K Buy
8,572
+2,625
+44% +$204K 0.01% 1178
2025
Q1
$475K Buy
5,947
+1,123
+23% +$101K 0.01% 1156
2024
Q4
$454K Buy
4,824
+199
+4% +$19.5K 0.01% 1115
2024
Q3
$468K Buy
+4,625
New +$451K 0.01% 900

Other funds holding AKAM

&Partners's AKAM Position: Q2 2026 in Review

&Partners reduced its Akamai (AKAM) stake by 9.2% in Q2 2026, selling an estimated $104K and leaving 8,184 shares worth $979K. The position accounts for ﹤0.01% of the portfolio, ranked #1425.

&Partners first reported a position in AKAM in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.03M in Q1 2026. 803 funds tracked by Wall St. Rank hold AKAM as of Q2 2026.

  • &Partners held 8,184 shares of Akamai worth $979K as of Q2 2026.
  • &Partners sold 832 Akamai shares in Q2 2026, an estimated $104K.
  • Akamai made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1425 holding.
  • &Partners first reported a position in Akamai in Q3 2024 and has held it in 8 quarters since.
  • &Partners's Akamai position peaked at $1.03M in Q1 2026.
  • 803 funds tracked by Wall St. Rank held Akamai as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.